Cyclo Therapeutics Inc (CYTH)
0.73
+0.03
(+4.43%)
USD |
NASDAQ |
Nov 22, 15:52
Cyclo Therapeutics Total Assets (Quarterly): 5.254M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.254M |
| June 30, 2024 | 4.718M |
| March 31, 2024 | 7.164M |
| December 31, 2023 | 13.25M |
| September 30, 2023 | 5.597M |
| June 30, 2023 | 4.643M |
| March 31, 2023 | 4.097M |
| December 31, 2022 | 4.215M |
| September 30, 2022 | 8.488M |
| June 30, 2022 | 11.84M |
| March 31, 2022 | 15.92M |
| December 31, 2021 | 19.52M |
| September 30, 2021 | 11.10M |
| June 30, 2021 | 14.24M |
| March 31, 2021 | 18.14M |
| December 31, 2020 | 14.19M |
| September 30, 2020 | 4.132M |
| June 30, 2020 | 2.262M |
| March 31, 2020 | 2.286M |
| December 31, 2019 | 4.113M |
| September 30, 2019 | 5.862M |
| June 30, 2019 | 7.591M |
| March 31, 2019 | 1.905M |
| December 31, 2018 | 2.918M |
| September 30, 2018 | 1.871M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.292M |
| March 31, 2018 | 1.401M |
| December 31, 2017 | 2.089M |
| September 30, 2017 | 2.170M |
| June 30, 2017 | 2.195M |
| March 31, 2017 | 2.678M |
| December 31, 2016 | 1.868M |
| September 30, 2016 | 3.234M |
| June 30, 2016 | 4.972M |
| March 31, 2016 | 4.030M |
| December 31, 2015 | 4.741M |
| September 30, 2015 | 5.841M |
| June 30, 2015 | 4.488M |
| March 31, 2015 | 4.905M |
| December 31, 2014 | 5.285M |
| September 30, 2014 | 5.618M |
| June 30, 2014 | 4.051M |
| March 31, 2014 | 3.362M |
| December 31, 2013 | 2.790M |
| September 30, 2013 | 2.843M |
| June 30, 2013 | 2.952M |
| March 31, 2013 | 2.798M |
| December 31, 2012 | 2.618M |
| September 30, 2012 | 2.667M |
| June 30, 2012 | 2.712M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.262M
Minimum
Jun 2020
19.52M
Maximum
Dec 2021
8.759M
Average
6.380M
Median
Total Assets (Quarterly) Benchmarks
| Stryker Corp | 43.83B |
| Biogen Inc | 28.31B |
| Pfizer Inc | 219.48B |
| Pacira BioSciences Inc | 1.522B |
| Moderna Inc | 15.80B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.73M |
| Shareholders Equity (Quarterly) | -13.47M |
| Debt to Equity Ratio | -0.9039 |
| Current Ratio | 0.174 |
| Net Debt Paydown Yield | -10.73% |